These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36301247)

  • 1. The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target.
    Mazzariol M; Manenti L; Vaglio A
    Curr Opin Rheumatol; 2023 Jan; 35(1):31-36. PubMed ID: 36301247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement in ANCA-associated glomerulonephritis.
    Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Roccatello D; Fenoglio R; Oddone V; Sciascia S
    Kidney Blood Press Res; 2022; 47(8):506-513. PubMed ID: 35665698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.
    García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA
    Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
    Trivioli G; Vaglio A
    Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement system activation in ANCA vasculitis: A translational success story?
    Kallenberg CG; Heeringa P
    Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Complement System and ANCA Associated Vasculitis in the Era of Anti-Complement Drugs.
    Kimoto Y; Horiuchi T
    Front Immunol; 2022; 13():926044. PubMed ID: 35812453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Lucientes-Continente L; Fernández-Juárez G; Márquez-Tirado B; Jiménez-Villegas L; Acevedo M; Cavero T; Cámara LS; Draibe J; Anton-Pampols P; Caravaca-Fontán F; Praga M; Villacorta J; Goicoechea de Jorge E
    Kidney Int; 2024 Jan; 105(1):177-188. PubMed ID: 37923132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological and clinical profiles of avacopan (TAVNEOS
    Maruyama Y; Yoshida T; Maruyama I
    Nihon Yakurigaku Zasshi; 2023 Sep; 158(5):399-407. PubMed ID: 37460300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early transition to avacopan from glucocorticoids applied during induction therapy for microscopic polyangiitis with rapidly progressive glomerulonephritis.
    Miyake H; Tanabe K; Yamaji S; Kihara T
    CEN Case Rep; 2024 Aug; 13(4):277-283. PubMed ID: 38093149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
    Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis.
    Korsten P; Baier E; Hakroush S; Tampe B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Inhibition in ANCA-Associated Vasculitis.
    Tesar V; Hruskova Z
    Front Immunol; 2022; 13():888816. PubMed ID: 35880179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avacopan as an additional therapeutic intervention to promote renal recovery in severe ANCA-associated vasculitis: A case report.
    Atrens AD; Hutton H; O'Sullivan E; Moore J; Madhan K
    Nephrology (Carlton); 2024 Feb; 29(2):105-107. PubMed ID: 37985226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis.
    Wester Trejo MAC; Trouw LA; Bajema IM
    Curr Opin Rheumatol; 2019 Jan; 31(1):3-8. PubMed ID: 30461541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological features of patients with antineutrophil cytoplasmic antibody-associated vasculitides concomitant with IgG4-related disease.
    Ma Y; Chen L; Xu Y; Han Q; Yu B; Yuan Y; Zhao J; Yang Y; Chen J; Han F
    Int J Rheum Dis; 2019 Dec; 22(12):2143-2150. PubMed ID: 31631507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.
    Baier E; Tampe D; Kluge IA; Hakroush S; Tampe B
    Front Immunol; 2022; 13():1054457. PubMed ID: 36439156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Yuan J; Gou SJ; Huang J; Hao J; Chen M; Zhao MH
    Arthritis Res Ther; 2012 Jun; 14(3):R140. PubMed ID: 22691190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.